Gainers
- Biophytis BPTS shares moved upwards by 37.54% to $8.5 during Monday's after-market session. The market value of their outstanding shares is at $106.8 million.
- Geron GERN shares increased by 5.09% to $1.65. Geron's trading volume hit 572.6K shares by close, accounting for 33.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $528.9 million.
- McKesson MCK shares moved upwards by 4.31% to $217.0. Trading volume for this security closed at 114.9K, accounting for 14.68% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $33.5 billion. As per the press release, Q2 earnings came out today.
- NeuroMetrix NURO stock increased by 3.55% to $8.75. The market value of their outstanding shares is at $49.2 million.
- Eton Pharmaceuticals ETON stock moved upwards by 3.32% to $6.52. The company's market cap stands at $160.3 million.
- Atreca BCEL shares increased by 3.17% to $6.49. The company's market cap stands at $239.4 million.
Losers
- Semler Scientific SMLR shares fell 21.28% to $117.9 during Monday's after-market session. The market value of their outstanding shares is at $796.2 million. As per the news, the Q3 earnings report came out today.
- Legend Biotech LEGN shares fell 7.22% to $48.9. The market value of their outstanding shares is at $7.0 billion.
- Neurocrine Biosciences NBIX stock fell 5.84% to $100.02. This security traded at a volume of 85.3K shares come close, making up 14.05% of its average volume over the last 100 days. The market value of their outstanding shares is at $9.4 billion. The company's, Q3 earnings came out today.
- Nutriband NTRB shares fell 3.31% to $6.15. The company's market cap stands at $45.5 million.
- MeiraGTx Hldgs MGTX stock declined by 3.06% to $19.97. The market value of their outstanding shares is at $884.9 million.
- Medigus MDGS stock declined by 2.65% to $1.47. The market value of their outstanding shares is at $35.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in